anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
AstraZeneca · conference-presentation

AstraZeneca | Investor Presentation Deck | 53 slides

53 pages · 4 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

AstraZeneca | Investor Presentation Deck | 53 slides

AstraZeneca · 2022-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 16 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Setup 4 slides 100% 4/4 slides 100% 4/4 slides · 9 hits
— 0/4 slides
— 0/4 slides
25% 1/4 slides 100% 4/4 slides
— 0/4 slides
Key Takeaways 4 slides 100% 4/4 slides 100% 4/4 slides · 25 hits
— 0/4 slides
— 0/4 slides
25% 1/4 slides 100% 4/4 slides · 7 hits 25% 1/4 slides KPI Overview 7 slides 100% 7/7 slides 100% 7/7 slides · 37 hits
— 0/7 slides
— 0/7 slides
14.3% 1/7 slides 100% 7/7 slides · 10 hits 71.4% 5/7 slides Section Divider 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides

Slide inventory

53
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Setup
02
other
Open slide detailBeat · Setup
03
filler
Open slide detailBeat · Setup
04
front_matter
Open slide detailBeat · Setup
05
transition
Open slide detail
06
The slide uses a three-column layout to categorize performance metrics and achievements.summarize
Open slide detailBeat · Key Takeaways
07
The slide presents two side-by-side tables summarizing revenue and growth percentages, with a footnote clarifying the exclusion of Vaxzevria in certain metrics.analyze_data
Open slide detailBeat · Key Takeaways
08
The slide uses a combination of a product portfolio grid and two pie charts to illustrate business diversification.summarize
Open slide detailBeat · Key Takeaways
09
The slide uses a four-column layout to categorize strategic growth drivers.summarize
Open slide detailBeat · Key TakeawaysLoop · Golden Circle
10
The slide uses a table to categorize pipeline progress by regulatory status and geography.summarize
Open slide detailBeat · KPI OverviewLoop · Golden Circle
11
Includes footnotes explaining CER (constant exchange rates), R&D, SG&A, and pp (percentage points).analyze_data
Open slide detailBeat · KPI OverviewLoop · Golden Circle
12
Includes footnotes regarding CER (constant exchange rates), R&D, SG&A, and percentage points.analyze_data
Open slide detailBeat · KPI OverviewLoop · Golden Circle
13
The slide uses a four-column layout to present financial projections and qualitative business drivers.analyze_data
Open slide detailBeat · KPI OverviewLoop · Golden Circle
14
transition
Open slide detailBeat · Section DividerLoop · Golden Circle
15
The waterfall chart includes a specific callout for acquisition-related debt.analyze_data
Open slide detailLoop · Golden Circle
16
transition
Open slide detailLoop · Golden Circle
17
Includes regional breakdown (US, Europe, ERoW, EM) and specific clinical/market drivers.analyze_data
Open slide detailLoop · Golden Circle
18
Includes legend for regional sales and collaboration revenue categories.analyze_data
Open slide detailLoop · Golden Circle
19
The slide uses stacked bar charts to visualize revenue growth by region (US, Europe, ERoW, EM) for two pharmaceutical products.analyze_data
Open slide detailLoop · Golden Circle
20
The slide uses a three-column layout to organize updates by congress, each supported by a specific clinical chart.summarize
Open slide detailLoop · Golden Circle
21
transition
Open slide detailLoop · Golden Circle
22
Includes a stacked bar chart for Farxiga revenue and a line chart for Lokelma market share.analyze_data
Open slide detailLoop · Golden Circle
23
Includes product-specific performance charts and bulleted highlights.analyze_data
Open slide detailLoop · Golden Circle
24
The slide uses a combination of big numbers and a table to illustrate the addressable patient population.quantify_opportunity
Open slide detailLoop · Golden Circle
25
The chart shows a stacked bar breakdown of revenue by region (China vs Ex-China) and COVID-19 vaccine sales over 9 quarters.analyze_data
Open slide detailLoop · Golden Circle
26
The slide uses a three-column layout to present product-specific updates.summarize
Open slide detailLoop · Golden Circle
27
The slide features a stylized human silhouette with digital/biological imagery, typical of a section transition in a corporate presentation.transition
Open slide detail
28
Slide 28 of a presentation, likely from AstraZeneca's financial reporting.analyze_data
Open slide detail
29
Uses a patient icon array to illustrate prevalence and a horizontal timeline/spectrum to map MOAs to disease severity.present_framework
Open slide detail
30
The slide uses a Gantt-style chart to visualize drug development phases.summarize
Open slide detail
31
closing_ask
Open slide detail
32
The slide uses a matrix structure (timeline vs. activity type) to organize upcoming milestones.plan_implementation
Open slide detail
33
The slide uses a four-pillar icon-based layout to summarize corporate strategy.summarize
Open slide detail
34
Slide 34 of the deck.summarize
Open slide detail
35
appendix
Open slide detail
36
The chart visualizes emission reduction paths for various companies, while the table ranks them by temperature alignment.compare_peers
Open slide detail
37
The slide presents two distinct tables side-by-side for different therapeutic areas.summarize
Open slide detail
38
analyze_data
Open slide detail
39
The slide uses a stylized silhouette of a human figure with internal molecular/cellular imagery.transition
Open slide detail
40
The slide uses a minimalist design with a large number '1' in a circle, suggesting this is the first section or a primary cover.front_matter
Open slide detail
41
The slide uses a matrix-like structure to map patient segments (NHA naive vs experienced) against disease stages (Hormone sensitive vs Castration resistant).frame_situation
Open slide detail
42
Includes ASCO GU 2022 conference branding.summarize
Open slide detail
43
Includes a patient segmentation diagram showing NHA-naïve vs. Prior NHA use populations.present_solution
Open slide detail
44
The slide features a stylized silhouette of a human figure with an internal molecular/antibody visualization.transition
Open slide detail
45
Includes ASCO GI 2022 badge and clinical trial references.frame_problem
Open slide detail
46
Includes ASCO GI 2022 callout and regulatory submission status.summarize
Open slide detail
47
The slide uses a flow-chart style diagram to map clinical trial targets to specific patient segments.present_framework
Open slide detail
48
The slide features a stylized silhouette of a human figure with a molecular/antibody illustration in the chest area.transition
Open slide detail
49
The slide uses a matrix-like structure to map clinical indications against treatment lines, emphasizing a 'replace/displace' strategy.plan_implementation
Open slide detail
50
The slide uses a matrix-style layout to map clinical trials (DESTINY series) across treatment lines and disease indications.plan_implementation
Open slide detail
51
The slide uses a matrix layout to map drug indications against patient populations and treatment lines.present_solution
Open slide detail
52
The slide uses a flow-chart style to segment patient populations.size_opportunity
Open slide detail
53
other
Open slide detail